MindMed | Investor Presentation Deck

Slide schematic 4/4

callout 1/1 source-note 1/1 table 1/1 title 1/1

Components 4

primary source-note data headline

Tools 2

table/data: Matrix comparing GAD and MDD across Preliminary Clinical Evidence, Large Market Opportunities, and Significant Need for New Treatments.

Problem Statement Canvas slide · 60%

Potential Best-in-Class Therapy with Novel MOA

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 1

matrix-nxn 90%

3x2 grid comparing clinical, market, and need factors across two disease states.

Find anything